Which Fitness App Social Challenges Work for Type 2 Diabetes?

Competition and support beat team challenges—but steps alone did not change diabetes markers

If you want a wearable challenge to keep you moving, choose a head-to-head competition or a dedicated accountability partner. A year-long randomized trial in adults with uncontrolled type 2 diabetes found that both formats increased daily steps by about 500 to 600 compared with step feedback alone. A pooled team challenge did not.

The more sobering result came from the same trial: those sustained step gains did not produce statistically significant between-group improvements in HbA1c or body weight at six or 12 months. Fitness-app design can change behavior. At the activity dose achieved here, it did not change the metabolic outcomes that matter most to many people with diabetes.

That distinction should shape how you use gamification. Treat it as a tool for maintaining an activity floor, not as a replacement for exercise training designed to improve glucose control.

The 12-month test of social accountability

In the iDiabetes randomized clinical trial, Mitesh Patel and colleagues assigned 361 adults with uncontrolled type 2 diabetes to one of four remotely monitored groups for 12 months. Participants had HbA1c values of at least 8% and a BMI of at least 25; the BMI criterion began at 30 and was lowered during recruitment.

Every active intervention used the same behavioral framework: loss-framed points, gradually rising step goals, a precommitment pledge, and daily progress messages. Participants could lose points when they missed goals, an approach intended to tap loss aversion. The researchers changed one feature across the three active groups: the social incentive.

• Competition: participants ranked against peers as individuals.
• Support: participants received encouragement from a motivational partner.
• Collaboration: participants pooled points with a group to reach shared thresholds.
• Control: participants received daily step feedback without the gamified social structure.

Competition and support each produced a statistically significant increase of roughly 500 to 600 daily steps versus control across the 12-month period. The trial did not show the usual early spike followed by a retreat toward baseline. That durability is meaningful: many digital activity programs look energetic for a few weeks and then quietly become another notification people swipe away.

Collaboration did not significantly increase steps compared with control. The result rules out the comforting assumption that any social layer will work if you add enough badges and a leaderboard.

Why the team format may have failed

The collaboration result deserves caution, not a grand theory about human nature. Most people in that arm were assigned to groups of strangers. When rewards depend on a pooled group score, each member can contribute less while still benefiting from everyone else's effort. That setup dilutes accountability.

It also means the trial did not settle whether collaborative challenges among close friends, partners, or family members work. Prior work cited by the investigators suggested that dyads with an existing relationship can outperform stranger pairings. The evidence supports individual competition and one-to-one support more directly than it supports, or disproves, every possible team challenge.

Other randomized studies point in the same direction for support-oriented designs. In overweight or obese veterans, Agarwal and colleagues' 12-week trial found that gamification with social support increased physical activity; loss-framed financial incentives added a separate boost. Among recently hospitalized adults, Greysen and colleagues found that a social-support gamification program improved step-based mobility after discharge. A text-based intervention also improved physical activity among postpartum people with hypertensive disorders of pregnancy in a randomized trial by Lewey and colleagues.

These studies involve different populations, follow-up periods, and intervention details, so they do not prove a universal effect size. They do support a narrower conclusion: social support and individually accountable gamification can increase physical activity across several clinical settings.

More steps, no significant HbA1c or weight change

The iDiabetes trial's metabolic results set the boundary on that conclusion. Despite the sustained step advantage in the competition and support groups, none of the gamification arms had a statistically significant between-group difference in HbA1c or body weight at six or 12 months.

This does not prove that an extra 500 to 600 steps per day has zero metabolic value for every person. The trial may have lacked power to detect a small effect, and people with type 2 diabetes vary in how they respond to lifestyle interventions. A 2025 systematic review of prediabetes phenotypes found substantial variation in metabolic response to lifestyle programs, although prediabetes is not the same population as uncontrolled type 2 diabetes.

Still, the trial did not establish HbA1c or weight benefit at this activity increment. That is the clinically useful answer. An intervention can be statistically successful at changing steps while failing to demonstrate a benefit on a metabolic endpoint. Steps are a behavioral outcome; HbA1c and body weight answer different questions.

Why structured exercise remains the better metabolic bet

The likely explanation is dose and type of exercise, though no direct study has identified the exact daily-step threshold at which glycemic benefit begins in type 2 diabetes. The iDiabetes intervention added ordinary ambulatory activity. It did not prescribe progressive loading, supervised sessions, or a combined training plan.

Those features appear in exercise programs with better metabolic evidence. A 2025 systematic review and meta-analysis of progressive resistance training in older adults with type 2 diabetes found significant reductions in HbA1c, body weight, and body fat. A 2024 network meta-analysis in older adults with type 2 diabetes ranked combined aerobic and resistance training as the best approach for blood-glucose control and found that supervised multimodal programs outperformed lower-intensity or single-modality approaches.

These comparisons do not let us calculate how many more steps someone needs. They do make one practical point hard to avoid: a step challenge should support a structured exercise plan when glucose control or body composition is the goal. It should not carry the whole assignment.

An upside that HbA1c cannot capture

Metabolic markers do not measure every possible benefit of becoming more active. A systematic review and meta-analysis by Picard and colleagues found that exercise training improved heart rate variability in people with type 2 diabetes. Heart rate variability measures aspects of cardiac autonomic function, which can decline with diabetic autonomic neuropathy.

The iDiabetes trial did not measure heart rate variability, so it cannot show that its extra steps improved autonomic function. That would be an inference, not a finding. But the broader exercise evidence gives a reason not to treat unchanged HbA1c as proof that sustained activity is worthless.

What to do with this evidence

Use a competition challenge with people you know, or recruit one reliable support partner. Keep the rules personal: each person should have a visible target and a clear record of whether they met it. A team pool may work for some established groups, but the best 12-month evidence found no advantage when mostly strangers shared the score.

Then add exercise with a metabolic purpose. Progressive resistance training and aerobic work belong in the plan if you want to improve glucose control, body weight, strength, or physical function. Discuss exercise changes with your clinician if you use glucose-lowering medication, have cardiovascular disease, neuropathy, or other diabetes complications.

Finally, expect engagement to vary outside a trial. In a real-world app study by Maher and colleagues, people used gamification features unevenly, and benefits differed with depth of engagement. A challenge only works after you open it. The iDiabetes trial shows which social structures can help you keep doing that; it does not turn a leaderboard into a diabetes treatment.

The verdict: Competition and one-to-one support can sustain a modest increase in daily activity for a year. For uncontrolled type 2 diabetes, pair that behavioral tool with structured exercise rather than expecting a few hundred extra steps to move HbA1c or the scale.